Vertex Pharmaceuticals
VRTX
VRTX
715 hedge funds and large institutions have $45.2B invested in Vertex Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 279 increasing their positions, 243 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
715
Holders Change
-20
Holders Change %
-2.72%
% of All Funds
15.55%
Holding in Top 10
15
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+15.38%
% of All Funds
0.33%
New
74
Increased
279
Reduced
243
Closed
84
Calls
$309M
Puts
$277M
Net Calls
+$32.1M
Net Calls Change
-$27.2M
Top Buyers
| 1 |
Nuveen Asset Management
Chicago,
Illinois
|
+$420M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$326M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$254M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$239M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$98.3M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$438M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$231M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$105M |
| 4 |
Jennison Associates
New York
|
-$83.6M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$78.2M |
